GLP-1 use among new mothers rose 24-fold from 2018 to early 2025, as researchers caution that evidence on GLP-1 exposure during breastfeeding remains limited.
youtu.be/q_7pcsLTChs

#postpartumweightloss #postpartum #GLP1 #Ozempic #Zepbound #Mounjaro #Wegovy #Semaglutide #Tirzepatide